CARGO Therapeutics Inc (NASDAQ:CRGX) currently has a daily average trading volume of 747.36K but it saw 1294129 shares traded in last market. With a market cap of 177.08M USD, the company’s current market price of $3.84 came falling about -3.27 while comparing to the previous closing price of $3.97. In past 52 weeks, the stock remained buoying in the range of price level as high as $25.45 and as low as $3.00.
Taking a look at 20-day trading activity of CARGO Therapeutics Inc (CRGX) gives us an average price of $4.34, while its current price level is -84.91% below from 52-week high level whereas it is 28.00% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $4.20 while that of 200 days or SMA-200 reads an average of $12.60. A closer look into the stock’s movement over the week reveals that its volatility is standing at 6.10% during that period while stretching the period over a month that decreases to 4.75%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 32.77 which implies that the stock is in neutral territory.
Truist downgraded its recommendation for the stock as a “Hold” from “Buy” on January 30, 2025 while assigning a price target range of $32-$7. Piper Sandler also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $34 and $4.
Over the week, CRGX’s stock price is moving -5.19% down while it is -13.90% when we observe its performance for the past one month. Year-to-date it is -73.37% down and over the past year, the stock is showing a downside performance of -79.88%.
Currently, CARGO Therapeutics Inc’s total number of outstanding shares is 46.05M with 0.57% of that held by the insiders while 115.75% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -69.65% and return on equity (ROE) at -65.94%. Stock’s beta reads 0.11. Stock has a price to book (P/B) ratio of 0.63. Its return on asset (ROA) is -55.12% on average.
